Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. - Wikidata - awgldk - TriplyDB

Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

http://www.wikidata.org/entity/Q33506083

about

Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung Tertiary Lymphoid Organs in Cancer Tissues Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together Immunogenic properties of archaeal species found in bioaerosols B cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infection.ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis The development of inducible bronchus-associated lymphoid tissue depends on IL-17.Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia.The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms.Development of virus-like particles for diagnostic and prophylactic biomedical applications Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function.Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link?Neonatal irradiation sensitizes mice to delayed pulmonary challenge Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction.Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses.CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.Regulation of inducible BALT formation and contribution to immunity and pathology.Delivery of antigens used for vaccination: recent advances and challenges.Lymphoid follicles in chronic lung diseases.Virus-based nanoparticles as platform technologies for modern vaccines.The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation.Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.Pulmonary dendritic cells: thinking globally, acting locally.Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy Administration of immunobiotic Lactobacillus plantarum delays but does not prevent lethal pneumovirus infection in Rag1-/- mice.Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection.Regulatory T cells prevent inducible BALT formation by dampening neutrophilic inflammation.IL-1α is Critical for Resistance Against Highly Virulent Aspergillus fumigatus Isolates.Tertiary lymphoid structures target the antitumor immune response to lung cancer.Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses.

P2860

Q26742160-10EF47F3-C640-46D3-B06F-4441B7FC6D24 Q26742168-D09A1EF1-4E9B-4D6C-BE16-DD0711AFE0BA Q26825031-D4DAC38C-6294-4283-853C-9184A6EBD3DD Q28067648-2BDC3E5E-69F5-49E3-A95E-D95FDC131D3B Q28741465-EB65F24E-7E98-474B-995C-3DCC326152D4 Q33638936-C3557E7D-B5E4-4D25-B36D-D9C3E32AC984 Q33703658-15AA03A8-5C95-46AB-A4F7-DE640FD81999 Q34191942-D77DA6A6-AC6C-4D26-8509-3FD5DC656046 Q34289051-8685B8F9-4C65-460D-8093-35149CBA7F1F Q34540385-2598F64D-3975-4066-86F9-C6CA3F021780 Q35103033-A2886C16-8DBC-455E-B91F-AB2B0662A16E Q35889469-E1ED77BD-A67B-4835-8D1A-9DDB9EC48413 Q36071784-76386C75-BCED-4C6E-A54A-52B50ACEBE51 Q36434174-6069AE2A-0E12-4965-BC72-B646FE3EFC6F Q36482753-4B8B56D4-99C3-4C7C-897B-6F04A569BED2 Q36630332-5F43A9AB-8222-4E51-834F-6B04EC58E5E8 Q36649674-1CD211D9-E5F2-4354-9661-81C0104EFF26 Q36667922-4C0DDA44-5B78-4D30-802F-0A8AEB1C75D9 Q36703898-85C3DFFD-84D0-4C86-AA11-E78D1FDD644E Q36870011-D647BF9A-CBF6-4F38-A670-92232E11F4CF Q37414746-B3B8B80F-86CE-4E5E-BAF8-38747B4A31EE Q37419245-C2F5951D-EB58-43A8-A535-12D3ED33A63E Q37588815-5883C9C7-988D-44CB-A008-1670B659AD0D Q37784683-BA8C8786-0E02-4162-A336-007344332992 Q38028969-42FD413E-439F-454D-97D8-BCDD14C88C8D Q38072845-45D3422F-1B46-4D11-88C2-E3278BD0F0A6 Q38702017-F4D3732A-98DD-4029-85F3-C93EC2B73D73 Q38903995-C305CD8D-17B6-4695-8526-518E894FDD45 Q38953303-6D17BECC-BA7B-4EA8-BF17-37AA713397AB Q39068831-CF05FC92-252A-4C75-A5A4-9CB8E742B25F Q39637458-E7F8507F-AD14-4EDE-BCAA-81E676CE0832 Q39727842-F8721F2F-6B7A-4C96-8C1A-0251330E926F Q40157987-9557C3CF-3E3B-4BE7-BF33-FBCF6F3D7996 Q40557011-F92FB1D6-2FE7-41ED-A7C2-060DBEB63EDA Q41157946-9934B966-B575-4DBB-BE05-4D5ED9E562E5 Q41994293-F7D77021-CE60-4993-A7B1-871082A53BA1 Q42992338-97F71DBE-9CD1-4DF6-A902-123471132CD1 Q44758803-5080FE1A-C8FA-4ECA-9B83-D84745620B3B Q49187990-FA1D0E83-C28B-4572-8F5A-421FEA9BF449

P2860

Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

http://www.wikidata.org/entity/Q33506083

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Inducible bronchus-associated ...... t diverse respiratory viruses.

@ast

Inducible bronchus-associated ...... t diverse respiratory viruses.

@en

type

label

Inducible bronchus-associated ...... t diverse respiratory viruses.

@ast

Inducible bronchus-associated ...... t diverse respiratory viruses.

@en

prefLabel

Inducible bronchus-associated ...... t diverse respiratory viruses.

@ast

Inducible bronchus-associated ...... t diverse respiratory viruses.

@en

P1433

Q33506083-A85CC320-482E-4A7E-BF18-3B1D8D49CACC

P1476

Q33506083-7D1F73AC-F6DF-4E92-9E5E-94839AA3FB1A

P2093

Q33506083-0FAE7683-1224-4458-8A5E-7EE6E041BC0C

Q33506083-4475D28B-C8AC-4948-A4F1-110778863C81

Q33506083-68C07C0D-604F-4E28-8462-299CDB3389AB

Q33506083-72E6BBE6-7E67-434A-9998-E608F4CFE791

Q33506083-81F4308A-9BFB-4494-A74D-E6B3C5CC4302

Q33506083-A071E7A0-B782-452B-ACEF-866695BB4DA3

Q33506083-A1BF6A1D-07F1-4635-911A-4FB99E5B85A2

Q33506083-A2117570-7061-4A5E-9C24-79D24DA031C3

Q33506083-C38BDE74-EBAB-4B84-BEC2-DEFCFD7D1F5F

Q33506083-D9812483-AAC1-4DD6-8C82-E7FCE1A808B2

P2860

Q33506083-0E2181BD-0FD4-45B6-B5AE-F553C03A8B62

Q33506083-1E247A88-84F0-4614-A69F-F67A98D05A9C

Q33506083-2C503ED4-4D63-468C-8484-FD79AC548D24

Q33506083-363CC6C5-F981-41BC-AAF0-22245A2055ED

Q33506083-552CE0A8-55D1-4592-A3DE-4E695D5A5142

Q33506083-5D9D7762-F501-4556-931B-0D5E6CD66FBF

Q33506083-72602FA7-85D2-4CB4-A92B-ABD5B2188EBD

Q33506083-805EC643-F302-4D73-A1CB-E39A364AF5B5

Q33506083-89A63DC6-FC6E-4FE6-9639-A6DE94A5B757

Q33506083-8F38A013-D494-4A80-B2FD-B0AB93184FC0

P304

Q33506083-B6FE8C3A-1B27-4763-9542-56F3DA63B6E8

P31

Q33506083-2FFDE41D-E7D8-4EB5-ADE6-AC1E3773A8D7

P356

Q33506083-CAF0D842-4B3F-4D46-89FA-0CD5DA3E3AC6

P407

Q33506083-435C8A3E-79CD-46D4-A078-CBFAE8EE8EFE

P433

Q33506083-1E6A8246-D371-4511-96A4-DE8B17D561BF

P478

Q33506083-AA82C877-09B2-43E3-8A54-1E3BF06C4040

P577

Q33506083-BE72A8BD-4C95-4B14-BF93-D6E83BC924F7

P5875

Q33506083-194F2238-0DDB-45A0-9584-DF977EE0DD56

P698

Q33506083-57432A9E-CDEE-4F9A-A813-835C494F4FAE

P921

Q33506083-3CB5B71D-C8B7-4C6F-953C-C5710FDDAB64

P932

Q33506083-AE5FA7E5-57F3-4039-ADD3-F1EA9FDF2188

P356

JOURNAL.PONE.0007142

P1433

P1476

Inducible bronchus-associated ...... t diverse respiratory viruses.

@en

P2093

Allen Harmsen

http://www.w3.org/2001/XMLSchema#string

Ann Harmsen

http://www.w3.org/2001/XMLSchema#string

Chris Broomell

http://www.w3.org/2001/XMLSchema#string

Dale L Barnard

http://www.w3.org/2001/XMLSchema#string

James A Wiley

http://www.w3.org/2001/XMLSchema#string

Laura E Richert

http://www.w3.org/2001/XMLSchema#string

Mark Jutila

http://www.w3.org/2001/XMLSchema#string

Mark Young

http://www.w3.org/2001/XMLSchema#string

Steve D Swain

http://www.w3.org/2001/XMLSchema#string

Trevor Douglas

http://www.w3.org/2001/XMLSchema#string

P2860

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

A critical role for OX40 in T cell-mediated immunopathology during lung viral infection

Crystal structure of a small heat-shock protein

Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis.

Development of secondary lymphoid organs

Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology.

Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation.

Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.

Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia

P304

e7142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0007142

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26831329

http://www.w3.org/2001/XMLSchema#string

P698

19774076

http://www.w3.org/2001/XMLSchema#string

P921

P932

2743193

http://www.w3.org/2001/XMLSchema#string